This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Mar;88(3):305.

doi: 10.1016/j.mayocp.2012.12.007. Epub 2013 Feb 27.

Off-label drug use: the bevacizumab story

Michael W Stewart

PMID: 23489456
DOI: 10.1016/j.mayocp.2012.12.007

Comment

Off-label drug use: the bevacizumab story

Michael W Stewart. Mayo Clin Proc. 2013 Mar.

. 2013 Mar;88(3):305.

doi: 10.1016/j.mayocp.2012.12.007. Epub 2013 Feb 27.

Author

Michael W Stewart

PMID: 23489456
DOI: 10.1016/j.mayocp.2012.12.007

No abstract available

PubMed Disclaimer

Comment in

In reply.
Wittich CM, Burkle CM, Lanier WL. Wittich CM, et al. Mayo Clin Proc. 2013 Mar;88(3):305-6. doi: 10.1016/j.mayocp.2012.12.008. Epub 2013 Feb 27. Mayo Clin Proc. 2013. PMID: 23489457 No abstract available.

Comment on

Ten common questions (and their answers) about off-label drug use.
Wittich CM, Burkle CM, Lanier WL. Wittich CM, et al. Mayo Clin Proc. 2012 Oct;87(10):982-90. doi: 10.1016/j.mayocp.2012.04.017. Epub 2012 Aug 6. Mayo Clin Proc. 2012. PMID: 22877654 Free PMC article.

Similar articles

In reply.
Wittich CM, Burkle CM, Lanier WL. Wittich CM, et al. Mayo Clin Proc. 2013 Mar;88(3):305-6. doi: 10.1016/j.mayocp.2012.12.008. Epub 2013 Feb 27. Mayo Clin Proc. 2013. PMID: 23489457 No abstract available.
Ten common questions (and their answers) about off-label drug use.
Wittich CM, Burkle CM, Lanier WL. Wittich CM, et al. Mayo Clin Proc. 2012 Oct;87(10):982-90. doi: 10.1016/j.mayocp.2012.04.017. Epub 2012 Aug 6. Mayo Clin Proc. 2012. PMID: 22877654 Free PMC article.
Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.
Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM. Kesselheim AS, et al. JAMA Intern Med. 2019 May 1;179(5):707-709. doi: 10.1001/jamainternmed.2018.8121. JAMA Intern Med. 2019. PMID: 30667474 Free PMC article.
Unlicensed and off-label drug use in children: implications for safety.
Choonara I, Conroy S. Choonara I, et al. Drug Saf. 2002;25(1):1-5. doi: 10.2165/00002018-200225010-00001. Drug Saf. 2002. PMID: 11820908 Review.
Trends in the off-label use of β-blockers in pediatric patients.
Kaley VR, Aregullin EO, Samuel BP, Vettukattil JJ. Kaley VR, et al. Pediatr Int. 2019 Nov;61(11):1071-1080. doi: 10.1111/ped.14015. Epub 2019 Nov 12. Pediatr Int. 2019. PMID: 31571355 Review.

See all similar articles

Cited by

Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.
Lin FL, Wang PY, Chuang YF, Wang JH, Wong VHY, Bui BV, Liu GS. Lin FL, et al. Mol Ther. 2020 Oct 7;28(10):2120-2138. doi: 10.1016/j.ymthe.2020.06.029. Epub 2020 Jun 30. Mol Ther. 2020. PMID: 32649860 Free PMC article. Review.
Exploring the Spectrum of VEGF Inhibitors' Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice.
Santorsola M, Capuozzo M, Nasti G, Sabbatino F, Di Mauro A, Di Mauro G, Vanni G, Maiolino P, Correra M, Granata V, Gualillo O, Berretta M, Ottaiano A. Santorsola M, et al. Cancers (Basel). 2024 Jan 13;16(2):350. doi: 10.3390/cancers16020350. Cancers (Basel). 2024. PMID: 38254839 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information